The Animal Welfare Institute (AWI) applauds the passage of the Horseracing Integrity and Safety Act (H.R. 1754/S. 4547) late Monday. This bill, approved by Congress as part of the fiscal year 2021 omnibus spending package, aims to reduce the fatalities and injuries that have plagued U.S. horseracing and end the reliance on performance-enhancing drugs to mask pain, inflammation, and other warning signs that often precede catastrophic breakdowns.

Sens. Mitch McConnell (R-KY), Kirsten Gillibrand (D-NY), Martha McSally (R-AZ), and Dianne Feinstein (D-CA) led the bill in the Senate, and Reps. Paul Tonko (D-NY) and Andy Barr (R-KY) led it in the House of Representatives. The Horseracing Integrity and Safety Act unanimously passed the House on September 29. The bill, which still needs to be signed by President Donald Trump as part of the overall spending package, is supported by animal protection groups and a wide range of stakeholders within the horseracing industry, including the owners/operators of all three Triple Crown racetracks, The Jockey Club, and Breedersโ€™ Cup Ltd.

The Horseracing Integrity and Safety Act would create an independent anti-doping authority that would set uniform national standards, testing procedures, and penalties for thoroughbred racing, replacing the inconsistent and often lax regulatory schemes that currently exist among 38 jurisdictions. The nonprofit U.S. Anti-Doping Agency โ€” widely recognized as the nationโ€™s premier anti-doping organization โ€” would handle enforcement, laboratory testing, and violations. Importantly, the bill would prohibit race-day medications, aligning U.S. standards with those abroad. The legislation also addresses racetrack safety by creating an accreditation program to ensure that tracks comply with maintenance procedures, as well as a national database to track injuries and fatalities.

Advertisement